NATIXIS position in BMY
BRISTOL-MYERS SQUIBB CO · Health Care
NATIXIS reported holding 2,519,137 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q2 2026 13F filing — a position valued at US$145.2M, representing 0.86% of its reported portfolio and ranking #12 among its reported holdings. NATIXIS has disclosed BMY holdings in 10 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NATIXIS's BMY position evolved
NATIXIS first disclosed a stake in BMY in Q4 2023 at 158,441 shares (US$8.1M). The position peaked in Q2 2026 at 2,519,137 shares, worth US$145.2M. Across 10 filings, NATIXIS increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,519,137 shares valued at US$145.2M — an increase of 451,073 shares quarter over quarter.. Notable position changes include a 67% trim in Q1 2025 (shares fell 23% over the following quarter), a 92% increase in Q3 2025 (shares rose 21% over the following quarter), a 125% increase in Q4 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 158.44K | $8.13M | New |
| Q2 2024 | 1.59M | $66.20M | New |
| Q3 2024 | 1.35M | $70.05M | Reduce |
| Q4 2024 | 1.24M | $70.41M | Reduce |
| Q1 2025 | 410.09K | $25.13M | Reduce |
| Q2 2025 | 358.39K | $16.59M | Reduce |
| Q3 2025 | 687.56K | $31.01M | Add |
| Q4 2025 | 1.55M | $83.37M | Add |
| Q1 2026 | 2.07M | $125.43M | Add |
| Q2 2026 | 2.52M | $145.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMY and 13F data
BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 28 other funds we track also report a position in BMY — the largest reported positions include Banque Cantonale Vaudoise (US$7.85B), Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMY
- Banque Cantonale Vaudoise 136.30K sh · $7.85B · Q2 2026
- Charles Schwab Investment Management 67.60M sh · $3.89B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 67.60M sh · $3.89B · Q2 2026
- Sixth Street Partners Management Company, L.P. 67.60M sh · $3.89B · Q2 2026
- AQR Capital Management 27.36M sh · $1.58B · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 27.36M sh · $1.58B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 24.92M sh · $1.44B · Q2 2026
- Independent Franchise Partners LLP 21.79M sh · $1.26B · Q2 2026
- Pzena Investment Management 17.01M sh · $979.95M · Q2 2026
FAQ
How long has NATIXIS held BMY?
NATIXIS has disclosed BMY holdings in 10 of the last 11 reported quarters, going back to Q4 2023.
What is NATIXIS's current position in BMY?
As of Q2 2026, NATIXIS holds 2.52M shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $145.15M, representing 0.86% of its reported portfolio and ranking #12.
Has NATIXIS been buying or selling BMY?
In the latest 13F filing (Q2 2026), NATIXIS increased its position in BMY. The position peaked in Q2 2026 at 2.52M shares.
Which other funds hold BMY?
Other major institutional holders of BMY include Banque Cantonale Vaudoise, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.